Efficacy of Pyloshot in combination with standard four‐drug antimicrobial treatment for <i>Helicobacter pylori</i> eradication: A randomized clinical trial
Based on the results of the present study, there was no significant difference between the effectiveness of treatment with Pyloshot probiotic and the standard four-drug therapy in patients with <i>H. pylori</i> infection. However, the incidence of side effects was lower in the group treated with Pyloshot.
Authors
- Hossein Fekr Azad (ORCID: https://orcid.org/0009-0003-3542-7944)
- Mehdi Pezeshgi Modarres (ORCID: https://orcid.org/0000-0001-6828-7800)
- Fatemeh-Sadat Razavinia
- Ahmad Hormati
- Seyed Saeid Sarkeshikian (ORCID: https://orcid.org/0000-0002-5702-7410)
- Abolfazl Mohammadbeigi
- Mehrdad Savabi Far (ORCID: https://orcid.org/0009-0005-2383-7238)
Institutions
- University of Qom (IR)
- Shariati Hospital (IR)
- Qom University of Medical Science and Health Services (IR)
- Tehran University of Medical Sciences (IR)
Publication Details
- Journal
- JGH Open
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/jgh3.70046
- Citations
- 1
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- Cotton Research and Development Corporation